SCHEMBL1354440

SCHEMBL1354440

[NH]Cc1cc(F)ccc1N

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
KEAP1 Q14145 1/20 0.41
IDO1 P14902 4/20 0.39
AGXT P21549 2/20 0.39
ATP4A P20648 1/20 0.37
ATP4B P51164 1/20 0.37
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A4 P31645 3/20 0.36
SLC6A3 Q01959 1/20 0.36
HTR1A P08908 1/20 0.33
KMT2A Q03164 1/20 0.33
DPP4 P27487 1/20 0.33
MPO P05164 1/20 0.32
BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2446106 0.82 ALDH1A1 (0.50) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL7197602 0.81 ALDH1A1 (0.54) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL1354441 0.79 ALDH1A1 (0.52) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL1548511 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL15597740 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL24394689 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL28846039 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL1616245 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL5293147 0.77 ALDH1A1 (0.50) ALDH1A1KEAP1IDO1AGXTATP4A
SCHEMBL1269438 0.77 ALDH1A1 (0.45) ALDH1A1KEAP1IDO1AGXTATP4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9023857-B2 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2015-05-05 US disclosed
EP-2391626-B1 SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS Univerzita Palackého v Olomouci (CZ) 2014-10-01 EP disclosed
US-20110287111-A1 SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287111-A1 SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS CDK6, CCNI, CDK2 ALDH1A1 1434/4885KEAP1 4178/4885IDO1 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.